Avoro Capital Advisors LLC

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 33
Total Value: 6406567714
Accession Number: 0001104659-25-048904
Form Type: 13F-HR
CIK: 0001633313
Manager Name: Avoro Capital Advisors LLC

Data Enrichment

97% identified

32 identified1 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

33 positions • $6,406,567.714K total value

33 positions

Manager:

SEC FilingSEC DataHachi Filing

Search and click to pin securities to the top

Page 2 of 2

Sort by:

OCULAR THERAPEUTIX, INC

Shares:

8060000(+0.0%)

Value:

$59.1B(-14.2%)

Centessa Pharmaceuticals plc

Shares:

4050000

Value:

$58.2B

89bio, Inc.

Shares:

6350000(+54.9%)

Value:

$46.2B(+44.0%)

MANNKIND CORP

Shares:

8750000(+0.0%)

Value:

$44.0B(-21.8%)

Vaxcyte, Inc.

Shares:

1000000(-14.9%)

Value:

$37.8B(-60.7%)

Tourmaline Bio, Inc.

Shares:

2425000(+9.1%)

Value:

$36.9B(-18.1%)

Ultragenyx Pharmaceutical Inc.

Shares:

830000(+0.0%)

Value:

$30.1B(-13.9%)

Taysha Gene Therapies, Inc.

Shares:

19999999(+0.0%)

Value:

$27.8B(-19.6%)

uniQure N.V.

Shares:

2175000(+0.0%)

Value:

$23.1B(-40.0%)

Monte Rosa Therapeutics, Inc.

Shares:

4645548(+6.9%)

Value:

$21.6B(-28.5%)

Autolus Therapeutics plc

Shares:

9910642(+0.0%)

Value:

$15.4B(-34.0%)

Septerna, Inc.

Shares:

1337500(+20.5%)

Value:

$7.7B(-69.5%)

Whitehawk Therapeutics, Inc.

Shares:

2849402(+0.0%)

Value:

$5.1B(-43.6%)

Instrument	Shares		Other Manager	Value
Ocular Therapeutix, Inc(OCULcusip67576A100)	8.1M	QoQ 0.00% (-0) YoY +12.74% (-911.1K)	All Managers (Combined)	$59.1M	QoQ -14.16% (-$9.8M) YoY -9.18% (-$6.0M)
Centessa Pharmaceuticals Plc(CNTAcusip152309100)	4.0M	QoQ NEW(+4.0M) YoY NEW(+4.0M)	All Managers (Combined)	$58.2M	QoQ NEW(+$58.2M) YoY NEW(+$58.2M)
89bio, Inc.(ETNBcusip282559103)	6.3M	QoQ +54.87% (+2.3M) YoY NEW(+6.3M)	All Managers (Combined)	$46.2M	QoQ +43.98% (+$14.1M) YoY NEW(+$46.2M)
Mannkind Corp(MNKDcusip56400P706)	8.8M	QoQ 0.00% (-0) YoY -2.77% (-250.0K)	All Managers (Combined)	$44.0M	QoQ -21.77% (-$12.3M) YoY +7.95% (-$3.2M)
Vaxcyte, Inc.(PCVXcusip92243G108)	1.0M	QoQ -14.89% (-175.0K) YoY +73.91% (-425.0K)	All Managers (Combined)	$37.8M	QoQ -60.74% (-$58.4M) YoY -3.86% (-$1.5M)
Tourmaline Bio, Inc.(TRMLcusip89157D105)	2.4M	QoQ +9.12% (-202.8K) YoY +9.12% (-202.8K)	All Managers (Combined)	$36.9M	QoQ -18.15% (-$8.2M) YoY -27.52% (-$14.0M)
Ultragenyx Pharmaceutical Inc.(RAREcusip90400D108)	830.0K	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$30.1M	QoQ -13.92% (-$4.9M) YoY -22.44% (-$8.7M)
Taysha Gene Therapies, Inc.(TSHAcusip877619106)	20.0M	QoQ 0.00% (-0) YoY +7.23% (-1.3M)	All Managers (Combined)	$27.8M	QoQ -19.65% (-$6.8M) YoY -48.06% (-$25.7M)
Uniqure N.V.(QUREcusipN90064101)	2.2M	QoQ 0.00% (-0) YoY NEW(+2.2M)	All Managers (Combined)	$23.1M	QoQ -39.97% (-$15.4M) YoY NEW(+$23.1M)
Monte Rosa Therapeutics, Inc.(GLUEcusip61225M102)	4.6M	QoQ +6.91% (-300.5K) YoY +2.43% (-110.5K)	All Managers (Combined)	$21.6M	QoQ -28.51% (-$8.6M) YoY -32.58% (-$10.4M)
Autolus Therapeutics Plc(AUTLcusip05280R100)	9.9M	QoQ 0.00% (-0) YoY -19.72% (-2.4M)	All Managers (Combined)	$15.4M	QoQ -34.04% (-$7.9M) YoY -80.49% (-$63.4M)
Septerna, Inc.(SEPNcusip81734D104)	1.3M	QoQ +20.49% (-227.5K) YoY NEW(+1.3M)	All Managers (Combined)	$7.7M	QoQ -69.53% (-$17.7M) YoY NEW(+$7.7M)
Whitehawk Therapeutics, Inc.(WHWKcusip00032Q104)	2.8M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$5.1M	QoQ -43.58% (-$3.9M) YoY -23.93% (-$1.6M)